ibandronic acid has been researched along with Body Weight in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauss, F; Endo, K; Hashimoto, J; Sakai, S; Shimizu, M; Shimonaka, Y; Sugimoto, M; Takeda, S; Yogo, K | 1 |
| Atzpodien, E; Bauss, F; Bohrmann, B; Pfister, T | 1 |
| Barrett, J; Gieschke, R; Goggin, T; Pillai, G; Steimer, JL; Worth, E | 1 |
| Christiansen, C; Clemmesen, B; Ravn, P; Riis, BJ | 1 |
2 trial(s) available for ibandronic acid and Body Weight
| Article | Year |
|---|---|
Population pharmacokinetics of ibandronate in Caucasian and Japanese healthy males and postmenopausal females.
Topics: Adult; Aged; Area Under Curve; Asian People; Body Weight; Bone Density Conservation Agents; Bone Diseases, Metabolic; Collagen Type I; Creatinine; Cross-Sectional Studies; Diphosphonates; Drug Administration Schedule; Female; Humans; Ibandronic Acid; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Peptides; Postmenopause; Retrospective Studies; Sex Factors; Tissue Distribution; White People | 2006 |
The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study.
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Analysis of Variance; Biomarkers; Body Height; Body Weight; Bone Density; Bone Resorption; Calcium, Dietary; Collagen; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Femur; Forearm; Humans; Ibandronic Acid; Middle Aged; Osteoporosis, Postmenopausal; Treatment Outcome | 1996 |
2 other study(ies) available for ibandronic acid and Body Weight
| Article | Year |
|---|---|
Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized rats.
Topics: Animals; Biomechanical Phenomena; Body Weight; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Resorption; Calcium; Diphosphonates; Dose-Response Relationship, Drug; Drug Synergism; Female; Femur; Ibandronic Acid; Lumbar Vertebrae; Osteogenesis; Ovariectomy; Phosphorus; Rats; Rats, Wistar; Stress, Mechanical; Vitamin D | 2015 |
Acute renal effects of intravenous bisphosphonates in the rat.
Topics: Animals; Body Weight; Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Female; Ibandronic Acid; Imidazoles; Injections, Intravenous; Kidney; Rats; Rats, Inbred Strains; Zoledronic Acid | 2005 |